Filings to increase in 2008, forecasts EMEA
According to European Medicines Agency (EMEA), 65 opinions on initial marketing authorizations for medicines for human use were adopted in 2007, 14 more than in 2006. The most-represented
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).